刘星雨, 孟鼎伦, 李舒弘, 郑春丽, 陆晨曦, 靳雅惠. 中药药对抗心衰药理作用的研究进展J. 药学学报, 2025, 60(9): 2667-2678. DOI: 10.16438/j.0513-4870.2025-0346
引用本文: 刘星雨, 孟鼎伦, 李舒弘, 郑春丽, 陆晨曦, 靳雅惠. 中药药对抗心衰药理作用的研究进展J. 药学学报, 2025, 60(9): 2667-2678. DOI: 10.16438/j.0513-4870.2025-0346
LIU Xing-yu, MENG Ding-lun, LI Shu-hong, ZHENG Chun-li, LU Chen-xi, JIN Ya-hui. Research progress on anti-heart failure pharmacological effect of herb pair in traditional Chinese medicineJ. Acta Pharmaceutica Sinica, 2025, 60(9): 2667-2678. DOI: 10.16438/j.0513-4870.2025-0346
Citation: LIU Xing-yu, MENG Ding-lun, LI Shu-hong, ZHENG Chun-li, LU Chen-xi, JIN Ya-hui. Research progress on anti-heart failure pharmacological effect of herb pair in traditional Chinese medicineJ. Acta Pharmaceutica Sinica, 2025, 60(9): 2667-2678. DOI: 10.16438/j.0513-4870.2025-0346

中药药对抗心衰药理作用的研究进展

Research progress on anti-heart failure pharmacological effect of herb pair in traditional Chinese medicine

  • 摘要: 目前, 心力衰竭(heart failure, HF) 已成为全球公共卫生领域的重大挑战, 其发病率与死亡率呈不断上升趋势。尽管现代医学采用的临床干预手段取得了一定成效, 但仍存在不良反应增多、病情反复及远期死亡率并未降低的情况。在此背景下, 基于传统中医药理论构建的药对配伍策略, 通过多成分协同与多靶点网络调控机制, 在心衰防治方面发挥重要作用。本文通过梳理近年来中药药对治疗心衰的相关文献, 整理了研究较为深入且具有代表性的药对16对, 它们主要通过减轻炎症反应、抗氧化应激、抗细胞凋亡、抑制心脏纤维化、调节神经内分泌紊乱及心肌微循环, 最终抑制或治疗心衰, 从而为临床制定个体化用药方案及新药开发拓展思路。

     

    Abstract: Heart failure (HF) has become a major challenge in global public health, and its incidence and lethality are on the rise. While the effectiveness of clinical interventions in modern medicine, they are accompanied by rising adverse drug reactions, recurring diseases, and no reduction in long-term mortality. In this context, herb pairing methods informed by traditional Chinese medicine theories, through mechanisms of multi-component synergy and multi-target network regulation, have been vital in HF prevention and treatment. In this study, we have gathered and analyzed recent investigations on the pharmacological effects of traditional Chinese medicine for HF, resulting in a list of 16 notable and representative herb pairs. Their main functions include reducing inflammation, countering oxidative stress, preventing apoptosis, inhibiting cardiac fibrosis, regulating neuroendocrine disorders and myocardial microcirculation, and ultimately preventing or treating HF, thus broadening the scope of personalized clinical drug regimens and the development of new therapeutic agents.

     

/

返回文章
返回